Inside Nephrology: A Weekly Review
Nefrologia
Advances in Nephrology: From PD Infections to Ciliopathies
This week we explore the latest in nephrology research, from updated guidelines for pediatric PD infections to advances in treating ciliopathies, lupus nephritis, and renal-cell carcinoma. We also discuss promising new antibiotics for UTIs and innovations in CKD management.
Accedi o Registrati per ascoltare questo episodio
Bibliografia
1. Clinical practice guideline for the prevention and management of peritoneal dialysis associated infections in children: 2024 update.
Authors: Warady BA, Same R, Borzych-Duzalka D, et al.
Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2024 Sep
PMID: 39313225
DOI: 10.1177/08968608241274096
2. Ciliopathies and the Kidney: A Review.
Authors: McConnachie DJ, Stow JL, Mallett AJ
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021 Mar
PMID: 33039432
DOI: 10.1053/j.ajkd.2020.08.012
3. RAASi, MRA and FGF-23 in CKD progression: the usual suspects?
Authors: Cianciolo G, Provenzano M, Hu L, et al.
Journal: Minerva urology and nephrology, 2026 Apr
PMID: 40910758
DOI: 10.23736/S2724-6051.25.06082-3
4. B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial.
Authors: Furie RA, Aroca G, Cascino MD, et al.
Journal: Annals of the rheumatic diseases, 2022 Jan
PMID: 34615636
DOI: 10.1136/annrheumdis-2021-220920
5. Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis: A Randomized Clinical Trial.
Authors: Kaye KS, Belley A, Barth P, et al.
Journal: JAMA, 2022 Oct 4
PMID: 36194218
DOI: 10.1001/jama.2022.17034
6. Ciliopathies and the Kidney: A Review.
Authors: McConnachie DJ, Stow JL, Mallett AJ
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021 Mar
PMID: 33039432
DOI: 10.1053/j.ajkd.2020.08.012
7. Long-Term Immunosuppression Management: Opportunities and Uncertainties.
Authors: Wojciechowski D, Wiseman A
Journal: Clinical journal of the American Society of Nephrology : CJASN, 2021 Aug
PMID: 33853841
DOI: 10.2215/CJN.15040920
8. Robotic Surgery Techniques to Improve Traditional Laparoscopy.
Authors: Williamson T, Song SE
Journal: JSLS : Journal of the Society of Laparoendoscopic Surgeons, 2022 Apr-Jun
PMID: 35655469
DOI: 10.4293/JSLS.2022.00002
9. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
Authors: Choueiri TK, Tomczak P, Park SH, et al.
Journal: The New England journal of medicine, 2021 Aug 19
PMID: 34407342
DOI: 10.1056/NEJMoa2106391
10. Post renal-transplant malignancy surveillance.
Authors: Manickavasagar R, Thuraisingham R
Journal: Clinical medicine (London, England), 2020 Mar
PMID: 32188647
DOI: 10.7861/clinmed.2019-0423
Authors: Warady BA, Same R, Borzych-Duzalka D, et al.
Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2024 Sep
PMID: 39313225
DOI: 10.1177/08968608241274096
2. Ciliopathies and the Kidney: A Review.
Authors: McConnachie DJ, Stow JL, Mallett AJ
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021 Mar
PMID: 33039432
DOI: 10.1053/j.ajkd.2020.08.012
3. RAASi, MRA and FGF-23 in CKD progression: the usual suspects?
Authors: Cianciolo G, Provenzano M, Hu L, et al.
Journal: Minerva urology and nephrology, 2026 Apr
PMID: 40910758
DOI: 10.23736/S2724-6051.25.06082-3
4. B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial.
Authors: Furie RA, Aroca G, Cascino MD, et al.
Journal: Annals of the rheumatic diseases, 2022 Jan
PMID: 34615636
DOI: 10.1136/annrheumdis-2021-220920
5. Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis: A Randomized Clinical Trial.
Authors: Kaye KS, Belley A, Barth P, et al.
Journal: JAMA, 2022 Oct 4
PMID: 36194218
DOI: 10.1001/jama.2022.17034
6. Ciliopathies and the Kidney: A Review.
Authors: McConnachie DJ, Stow JL, Mallett AJ
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021 Mar
PMID: 33039432
DOI: 10.1053/j.ajkd.2020.08.012
7. Long-Term Immunosuppression Management: Opportunities and Uncertainties.
Authors: Wojciechowski D, Wiseman A
Journal: Clinical journal of the American Society of Nephrology : CJASN, 2021 Aug
PMID: 33853841
DOI: 10.2215/CJN.15040920
8. Robotic Surgery Techniques to Improve Traditional Laparoscopy.
Authors: Williamson T, Song SE
Journal: JSLS : Journal of the Society of Laparoendoscopic Surgeons, 2022 Apr-Jun
PMID: 35655469
DOI: 10.4293/JSLS.2022.00002
9. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
Authors: Choueiri TK, Tomczak P, Park SH, et al.
Journal: The New England journal of medicine, 2021 Aug 19
PMID: 34407342
DOI: 10.1056/NEJMoa2106391
10. Post renal-transplant malignancy surveillance.
Authors: Manickavasagar R, Thuraisingham R
Journal: Clinical medicine (London, England), 2020 Mar
PMID: 32188647
DOI: 10.7861/clinmed.2019-0423
